Eterna Therapeutics
ERNA
#10413
Rank
A$19.61 M
Marketcap
A$16.82
Share price
-3.77%
Change (1 day)
216.90%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2025 (TTM): A-$111.33

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is A-$107.59. In 2022 the company made an earnings per share (EPS) of A-$176.52 an increase over its 2021 EPS that were of A-$1,166.

EPS history for Eterna Therapeutics from 2021 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$111.33
2022A-$176.52-84.86%
2021A-$1,166

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
A$3.59-103.34%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
A-$2.99-97.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
A-$2.83-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
A-$0.18-99.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
A$1.92-101.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
A$1.00-100.93%๐Ÿ‡บ๐Ÿ‡ธ USA